查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1663438

基於人工智慧的數位病理學市場，按神經網路、按組件、按應用、按最終用途、按國家和地區分類 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

AI-based Digital Pathology Market, By Neural Network, By Component, By Application, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 381 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年基於人工智慧的數位病理學市場規模價值為 8,560 萬美元，2025 年至 2032 年的複合年成長率為 15.80%。

基於人工智慧的數位病理學市場-市場動態

個人化醫療需求不斷成長

由於個人化醫療的需求不斷成長，基於人工智慧的數位病理學市場預計未來將會成長。根據每位病人獨特的需求、喜好和特徵量身訂做醫療和治療被稱為個人化醫療。個人化醫療變得越來越必要，透過根據每個患者獨特的基因特徵、生活方式選擇和疾病特徵量身定做治療來提高療效並減少副作用。透過更準確、更有效地分析基因資料和醫學影像，基於人工智慧的數位病理學可以實現更精確的診斷、更好地識別疾病亞型以及製定適合每位患者特定生物學特徵的客製化治療方案，從而支持個人化醫療。例如，美國專業會員組織個人化醫療聯盟於 2023 年 2 月發布的一份報告指出，2022 年批准了 12 種新的個人化藥物，約佔所有新療法的 34%，與前幾年相比有顯著成長。因此，由於對客製化治療的需求不斷成長，基於人工智慧的數位病理學市場正在擴大。

基於人工智慧的數位病理學市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 15.80%

根據神經網路細分，預計卷積神經網路 (CNN) 將在 2024 年佔據最大市場佔有率

根據應用細分，藥物發現是 2024 年的領先領域

根據最終用途細分，醫院和參考實驗室是 2024 年的主要細分市場

從地區來看，亞太地區是 2024 年最大的收入來源

基於人工智慧的數位病理學市場-細分分析：

全球基於人工智慧的數位病理學市場根據神經網路、組件、應用、最終用途和地區進行細分。

根據組件，市場分為掃描器和軟體。 2024 年，由於人工智慧軟體在數位病理學中的應用越來越多，軟體類別將佔據市場主導地位，而病理學家的時間、準確性和結果速度的下降推動了這一趨勢，使醫生能夠評估患者的健康狀況并快速安排恢復藥物。此外，人工智慧可有效用於儲存患者健康資料並檢索結果，這將在研究期間增加對基於人工智慧的數位病理學軟體的需求。

根據最終用途，市場分為醫院和參考實驗室、製藥和生物技術公司以及學術和研究機構。 2024 年，醫院和參考實驗室類別佔據主導市場。醫院和參考實驗室每天可能會處理越來越多的病理相關病例。病理學工作負擔越來越重，需要使用人工智慧，因為它能夠產生可靠的結果，並且節省時間。此外，借助人工智慧，醫院可以減少處理更多病例所需的病理學家數量。這將為未來幾年全球基於人工智慧的數位病理學市場的成長進一步開闢新的途徑。

基於人工智慧的數位病理學市場-地理洞察

2024 年，亞太地區在全球基於人工智慧的數位病理學市場中佔據主導地位。由於人工智慧在中國和印度等發展中國家的醫療保健領域的應用不斷擴大，基於人工智慧的數位病理學市場正在擴大。根據 NASSCOM 的數據，到 2025 年，印度醫療保健 AI 市場預計將以 40% 的複合年成長率擴張。這表明人工智慧在醫學領域的應用日益廣泛，由於人工智慧能夠快速完成重複任務並節省病理學家的時間，因此可以促進其在病理學中的應用。由於人工智慧可以完成一些與病理學家相關的職責，該領域的低階病理學家的存在正在推動醫療保健從業者使用它，從而增加了研究期間對它的需求。

然而，在整個預測期內，由於遠距醫療的使用日益增多，預計北美地區的複合年成長率將最快。由於嚴格的封鎖要求，COVID-19 鼓勵使用遠距醫療代替面對面診療。美國衛生與公眾服務部稱，自疫情爆發以來，美國健保受益人使用遠距醫療的頻率已提高。在美國，2020 年面對面就診次數為 9.89 億次，高於 2019 年的 11 億次。

基於人工智慧的數位病理學市場-競爭格局：

DoMore Diagnostics AS、Aiforia Technologies、Aiosyn、Deep Bio、F. Hoffmann-La Roche 等基於人工智慧的數位病理學市場的領先企業正專注於創造尖端產品，例如先進的癌症檢測儀器，以提高患者的治療效果、加快流程並提高診斷精度。人工智慧驅動的先進癌症檢測工具使用深度學習模型和機器學習演算法來評估病理切片和醫學影像，提高腫瘤識別和分類的準確性。例如，2022 年 2 月，Crosscope Inc. 和 MindPeak GmbH 合作，將 MindPeak 的影像分析工具納入 Crosscope 的數位病理學平台。此次合作提升了 Crossscope 的 AI 能力，使其能夠提供完整的數位病理學解決方案。透過順利整合尖端的 AI 工具，此次合作旨在簡化組織病理學工作流程，幫助病理學家提高實驗室生產力，並為 ER、PR 和 Ki-67 IHC 分析提供及時且重要的診斷。預計整合後患者的治療效果將會改善。

近期發展

2024 年 1 月：羅氏宣布已完成一項合併協議，收購位於加州柏克萊的美國私人企業 Carmot Therapeutics, Inc.（「Carmot」）。 Carmot 的研究和開發組合包括一系列臨床前研究和臨床階段的口服和皮下腸促胰島素，具有治療糖尿病和非糖尿病患者肥胖症的最佳潛力。

2023 年 10 月：在雲端服務供應商 Amazon Web Services, Inc. 的協助下，F. Hoffmann-La Roche Ltd. 和 Ibex Medical Analytics Ltd. 合作提供人工智慧癌症偵測解決方案。透過 Navify Digital Pathology 軟體平台，此次合作旨在為病理實驗室提供 Ibex 的人工智慧驅動決策支援功能。臨床醫生可以透過這種整合獲得診斷前列腺癌和乳癌的幫助。

2023 年 9 月：在歐洲、加拿大和亞太市場，Hologic, Inc. 和拜耳股份公司聯手提供增強乳房 X 光攝影 (CEM) 解決方案，以便更好地檢測乳癌。透過整合拜耳和 Hologic 的技術，該聯盟希望能夠在乳房 X 光檢查期間更輕鬆地應用造影劑。此次合作的主要目的是為放射科醫生提供完整的產品包、實踐指導和順暢的 CEM 工作流程整合。

2023 年 6 月：美國數位和計算病理學解決方案供應商 Proscia Inc. 與 MindPeak GmbH 合作。透過緊密協調的人工智慧工作流程，此次合作旨在幫助病理學家得出更有效、更有知識、可重複的臨床結論。目標是讓癌症患者更有機會獲得更好的診斷。

目錄

第 1 章：基於人工智慧的數位病理學市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 基於人工智慧的數位病理學市場片段（按神經網路）
    • 基於人工智慧的數位病理學市場片段（按組件）
    • 基於人工智慧的數位病理學市場片段（按應用）
    • 基於人工智慧的數位病理學市場片段（按最終用途分類）
    • 各國基於人工智慧的數位病理學市場片段
    • 基於人工智慧的數位病理學市場片段（按地區）
  • 競爭洞察

第 3 章：基於人工智慧的數位病理學關鍵市場趨勢

  • 基於人工智慧的數位病理學市場促進因素
    • 市場促進因素的影響分析
  • 基於人工智慧的數位病理學市場限制
    • 市場限制的影響分析
  • 基於人工智慧的數位病理學市場機會
  • 基於人工智慧的數位病理學市場未來趨勢

第 4 章：基於人工智慧的數位病理學產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章：基於人工智慧的數位病理學市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠肺炎疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長領域
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基於人工智慧的數位病理學市場格局

  • 2024 年基於人工智慧的數位病理學市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：基於人工智慧的數位病理學市場 - 按神經網路

  • 概述
    • 透過神經網路進行細分佔有率分析
    • 生成對抗網路（GANS）
    • 循環神經網路 (RNN)
    • 卷積神經網路 (CNN)
    • 其他

第 8 章：基於人工智慧的數位病理學市場 - 按組件

  • 概述
    • 按組件分類的細分市場佔有率分析
    • 掃描儀
    • 軟體

第 9 章：基於人工智慧的數位病理學市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 藥物研發
    • 臨床工作流程
    • 培訓與教育
    • 疾病診斷與預後

第 10 章：基於人工智慧的數位病理學市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院和參考實驗室
    • 製藥及生技公司
    • 學術及研究機構

第 11 章：基於人工智慧的數位病理學市場-按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美基於人工智慧的數位病理學主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按神經網路）
    • 北美市場規模及預測（按組件分類）
    • 北美市場規模與預測，按應用分類
    • 北美市場規模和預測，按最終用途
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲基於人工智慧的數位病理學主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模及預測（透過神經網路）
    • 歐洲市場規模及預測（按組成部分）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模和預測，按最終用途
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區基於人工智慧的數位病理學主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太市場規模及預測（依神經網路）
    • 亞太市場規模及預測（按組成部分）
    • 亞太市場規模及預測（按應用分類）
    • 亞太市場規模及預測（依最終用途分類）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲基於人工智慧的數位病理學主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（透過神經網路）
    • 拉丁美洲市場規模及預測（按組成部分）
    • 拉丁美洲市場規模與預測，按應用分類
    • 拉丁美洲市場規模及預測（依最終用途分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲基於人工智慧的數位病理學主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（神經網路）
    • 中東和非洲市場規模及預測（按組成部分）
    • 中東和非洲市場規模及預測（按應用分類）
    • 中東和非洲市場規模及預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 12 章：主要供應商分析-基於人工智慧的數位病理學產業

  • 競爭儀錶板
  • 公司簡介
    • DoMore Diagnostics AS
    • Aiforia Technologies
    • Aiosyn
    • Deep Bio
    • F. Hoffmann-La Roche
    • Akoya Biosciences
    • deepPath
    • Hologic
    • Konfoong Biotech International
    • Koninklijke Philips NV
    • 4D Path
    • Lumea
    • Ibex Medical Analytics
    • Indica Labs
    • Mindpeak
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4620

REPORT HIGHLIGHT

AI-based Digital Pathology Market size was valued at US$ 85.6 Million in 2024, expanding at a CAGR of 15.80% from 2025 to 2032.

AI-based digital pathology is a cutting-edge method of using digital technologies and artificial intelligence to diagnose and analyze illnesses. In order to identify patterns, anomalies, and particular disease signs, pathology slides are digitized into high-resolution images and subsequently sent to AI algorithms for analysis. By automating repetitive procedures, increasing diagnostic precision, and spotting minute details that would be overlooked during manual inspection, these AI systems might help pathologists. The AI-based digital pathology market is growing as a result of the growing emphasis on hospital cost control and efficiency enhancement, the rising need for technologically sophisticated solutions, and the rising number of incorrect diagnoses. Additionally, it is anticipated that government-funded research initiatives that support the creation of cutting-edge digital tools for pathology would support the AI-based digital pathology market growth.

AI-based Digital Pathology Market- Market Dynamics

Growing demand for personalized medication

The market for AI-based digital pathology is anticipated to increase in the future due to the growing demand for personalized medication. Customizing medical care and treatment to each patient's unique needs, preferences, and traits is known as personalized medicine. Personalized medicine is becoming more and more necessary in order to improve efficacy and decrease side effects by customizing therapies to each patient's unique genetic profile, lifestyle choices, and illness features. By making it possible to analyze genetic data and medical images more accurately and efficiently, AI-based digital pathology supports personalized medicine by facilitating more precise diagnosis, improved identification of disease subtypes, and customized treatment regimens that fit each patient's particular biological profile. For instance, a report released in February 2023 by the US-based professional membership organization Personalized Medicine Coalition stated that the approval of 12 new personalized medications in 2022-roughly 34% of all new therapies-represented a notable increase over prior years. Thus, the market for AI-based digital pathology is expanding due to the growing demand for tailored therapy.

AI-based Digital Pathology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.80% over the forecast period (2025-2032)

Based on neural network segmentation, the convolutional neural networks (CNNs) were predicted to show maximum market share in the year 2024

Based on application segmentation, drug discovery was the leading segment in 2024

Based on end use segmentation, hospitals & reference laboratories were the leading segment in 2024

On the basis of region, Asia-Pacific was the leading revenue generator in 2024

AI-based Digital Pathology Market- Segmentation Analysis:

The Global AI-based Digital Pathology Market is segmented on the basis of Neural Network, Component, Application, End Use, and Region.

On the basis of component, the market is segregated into Scanners and Software. In 2024, the market was dominated by the software category due to the increasing use of artificial intelligence software in digital pathology, which has been fueled by a decrease in pathologists' time, accuracy, and speed of results, enabling physicians to assess a patient's health and schedule recovery medication rapidly. Additionally, AI may be used effectively to store patient health data and retrieve results, which will increase the demand for AI-based digital pathology software during the study period.

Based on end use, the market is divided into Hospitals & Reference Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. In 2024, the hospitals & reference laboratories category held a dominant market share. Hospitals and reference labs will probably deal with an increasing number of pathology-related cases every day. The increasing burden for pathology jobs will need the use of AI due to its ability to produce reliable results and its time-saving capabilities. Additionally, hospitals can reduce the number of pathologists they require to manage more cases thanks to AI. This will further open up new avenues for the global AI-based digital pathology market to grow in the years to come.

AI-based Digital Pathology Market- Geographical Insights

In 2024, Asia-Pacific held a dominant position in the global market for AI-based Digital Pathology. The market for AI-based digital pathology is expanding due to the expanding application of AI in healthcare sectors in developing nations like China and India. By 2025, the healthcare AI market in India is anticipated to expand at a 40% CAGR, according to NASSCOM. This illustrates the growing usage of AI in the medical field, which could encourage its application in pathology due to its speedy completion of repetitive tasks and capacity to save pathologists time. Because artificial intelligence can do some pathologist-related duties, the presence of lower-level pathologists in the area is pushing healthcare practitioners to use it, increasing demand for it during the research period.

However, throughout the projected period, the North America region is anticipated to see the fastest CAGR because of the growing use of telemedicine. Due to strict lockdown requirements, COVID-19 encouraged the use of telemedicine instead of in-person sessions. Medicare beneficiaries in the US have been using telemedicine more frequently since the epidemic, according to the US Department of Health and Human Services. In the United States, there were 989 million in-person medical visits in 2020, up from 1.1 billion in 2019. By 2020, there were almost 52.7 million telemedicine appointments, up from 8,40,000 in 2019. AI-based technologies that assist physicians in treating patients remotely will be required as this trend, which is anticipated to increase due to decreased transaction costs, develops.

AI-based Digital Pathology Market- Competitive Landscape:

Leading players in the AI-based digital pathology market, such as DoMore Diagnostics AS, Aiforia Technologies, Aiosyn, Deep Bio, F. Hoffmann-La Roche, and others, are concentrating on creating cutting-edge products, such as sophisticated cancer detection instruments to boost patient outcomes, expedite processes, and increase diagnostic precision. AI-powered advanced cancer detection tools use deep learning models and machine learning algorithms to evaluate pathology slides and medical images, improving the precision of tumour identification and classification. For instance, in February 2022, Crosscope Inc. and MindPeak GmbH partnered to include MindPeak's image analysis tools into Crosscope's Digital Pathology platform. Crosscope's AI capabilities are improved by this collaboration, allowing them to offer complete digital pathology solutions. Through the smooth integration of cutting-edge AI tools, the collaboration seeks to streamline Histopathology workflows, assisting pathologists in enhancing lab productivity and providing prompt and significant diagnoses for ER, PR, and Ki-67 IHC analysis. Treatment outcomes for patients are expected to improve as a result of the integration.

Recent Development

January 2024: Roche declared that it had finalized a merger deal to buy Berkeley, California-based Carmot Therapeutics, Inc. ("Carmot"), a privately held US business. Carmot's research and development portfolio includes a range of preclinical studies and clinically staged oral and subcutaneous incretins with best-in-class potential to treat obesity in individuals with and without diabetes.

October 2023: With the help of cloud service provider Amazon Web Services, Inc., F. Hoffmann-La Roche Ltd. and Ibex Medical Analytics Ltd. have partnered to offer AI-powered cancer detection solutions. Through the Navify Digital Pathology software platform, this partnership seeks to provide pathology labs with access to Ibex's AI-driven decision support capabilities. Clinicians can get help diagnosing prostate and breast cancer through this integration.

September 2023: In the European, Canadian, and Asia Pacific markets, Hologic, Inc. and Bayer AG have teamed together to offer contrast-enhanced mammography (CEM) solutions for better breast cancer detection. By combining Bayer and Hologic's technology, the alliance hopes to make it easier to apply contrast media during mammography exams. The collaboration is centred on offering radiologists complete product bundles, practical instruction, and smooth CEM workflow integration.

June 2023: Proscia Inc., a U.S.-based supplier of digital and computational pathology solutions, has partnered with MindPeak GmbH. Through closely coordinated AI-powered workflows, this collaboration seeks to assist pathologists in reaching more effective, knowledgeable, and repeatable clinical conclusions. The objective is to increase cancer patients' access to better diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • DoMore Diagnostics AS
  • Aiforia Technologies
  • Aiosyn
  • Deep Bio
  • F. Hoffmann-La Roche
  • Akoya Biosciences
  • deepPath
  • Hologic
  • Konfoong Biotech International
  • Koninklijke Philips N.V.
  • 4D Path
  • Lumea
  • Ibex Medical Analytics
  • Indica Labs
  • Mindpeak
  • Others

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY NEURAL NETWORK- MARKET ANALYSIS, 2019 - 2032

  • Generative adversarial networks (GANS)
  • Recurrent neural networks (RNNs)
  • Convolutional neural networks (CNNs)
  • Others

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Scanners
  • Software

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery
  • Clinical Workflow
  • Training & Education
  • Disease Diagnosis & Prognosis

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Reference Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI-based Digital Pathology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI-based Digital Pathology Market Snippet by Neural Network
    • 2.1.2. AI-based Digital Pathology Market Snippet by Component
    • 2.1.3. AI-based Digital Pathology Market Snippet by Application
    • 2.1.4. AI-based Digital Pathology Market Snippet by End Use
    • 2.1.5. AI-based Digital Pathology Market Snippet by Country
    • 2.1.6. AI-based Digital Pathology Market Snippet by Region
  • 2.2. Competitive Insights

3. AI-based Digital Pathology Key Market Trends

  • 3.1. AI-based Digital Pathology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI-based Digital Pathology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI-based Digital Pathology Market Opportunities
  • 3.4. AI-based Digital Pathology Market Future Trends

4. AI-based Digital Pathology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI-based Digital Pathology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI-based Digital Pathology Market Landscape

  • 6.1. AI-based Digital Pathology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI-based Digital Pathology Market - By Neural Network

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Neural Network, 2024 & 2032 (%)
    • 7.1.2. Generative adversarial networks (GANS)
    • 7.1.3. Recurrent neural networks (RNNs)
    • 7.1.4. Convolutional neural networks (CNNs)
    • 7.1.5. Others

8. AI-based Digital Pathology Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 8.1.2. Scanners
    • 8.1.3. Software

9. AI-based Digital Pathology Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery
    • 9.1.3. Clinical Workflow
    • 9.1.4. Training & Education
    • 9.1.5. Disease Diagnosis & Prognosis

10. AI-based Digital Pathology Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Reference Laboratories
    • 10.1.3. Pharmaceutical & Biotechnology Companies
    • 10.1.4. Academic & Research Institutes

11. AI-based Digital Pathology Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. AI-based Digital Pathology Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. AI-based Digital Pathology Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. France
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. France Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.9.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. Italy
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. Italy Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.10.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Spain
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. United Kingdom
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. United Kingdom Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.12.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. Russia
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Russia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Netherlands
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Netherlands Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Sweden
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Sweden Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.2. Poland Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. AI-based Digital Pathology Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. South Korea
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. South Korea Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. Japan
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. Japan Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.11.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. AI-based Digital Pathology Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. AI-based Digital Pathology Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- AI-based Digital Pathology Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. DoMore Diagnostics AS
    • 12.2.2. Aiforia Technologies
    • 12.2.3. Aiosyn
    • 12.2.4. Deep Bio
    • 12.2.5. F. Hoffmann-La Roche
    • 12.2.6. Akoya Biosciences
    • 12.2.7. deepPath
    • 12.2.8. Hologic
    • 12.2.9. Konfoong Biotech International
    • 12.2.10. Koninklijke Philips N.V.
    • 12.2.11. 4D Path
    • 12.2.12. Lumea
    • 12.2.13. Ibex Medical Analytics
    • 12.2.14. Indica Labs
    • 12.2.15. Mindpeak
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us